234 related articles for article (PubMed ID: 20081319)
1. IL-1B polymorphism in association with initial intravenous immunoglobulin treatment failure in Taiwanese children with Kawasaki disease.
Weng KP; Hsieh KS; Ho TY; Huang SH; Lai CR; Chiu YT; Huang SC; Lin CC; Hwang YT; Ger LP
Circ J; 2010 Mar; 74(3):544-51. PubMed ID: 20081319
[TBL] [Abstract][Full Text] [Related]
2. Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients.
Wang Z; Xu Y; Zhou H; Wang Y; Li W; Lu Z; Jiang Z; Gu X; Zheng H; Zeng L; Huang P; Zhang L; Gu X
Cardiovasc Ther; 2020; 2020():3568608. PubMed ID: 32256707
[TBL] [Abstract][Full Text] [Related]
3. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD
Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
[TBL] [Abstract][Full Text] [Related]
4. The
Fu LY; Qiu X; Deng QL; Huang P; Pi L; Xu Y; Che D; Zhou H; Lu Z; Tan Y; Jiang Z; Zhang L; Liu T; Gu X
J Immunol Res; 2019; 2019():4730507. PubMed ID: 31093510
[TBL] [Abstract][Full Text] [Related]
5. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.
Lin MT; Chang CH; Sun LC; Liu HM; Chang HW; Chen CA; Chiu SN; Lu CW; Chang LY; Wang JK; Wu MH
J Formos Med Assoc; 2016 May; 115(5):350-5. PubMed ID: 25910931
[TBL] [Abstract][Full Text] [Related]
7. The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease.
Samadli S; Liu FF; Mammadov G; Wang JJ; Liu HH; Wu YF; Luo HH; Wu Y; Chen WX; Zhang DD; Wei W; Hu P
Pediatr Rheumatol Online J; 2019 Jul; 17(1):53. PubMed ID: 31366406
[TBL] [Abstract][Full Text] [Related]
8. The factors affecting the disease course in Kawasaki disease.
Arslanoglu Aydin E; Ertugrul I; Bilginer Y; Batu ED; Sonmez HE; Demir S; Arici ZS; Sag E; Alehan D; Ozen S
Rheumatol Int; 2019 Aug; 39(8):1343-1349. PubMed ID: 31139951
[TBL] [Abstract][Full Text] [Related]
9. Higher efficacy of infliximab than immunoglobulin on Kawasaki disease, a meta-analysis.
Li X; Tang Y; Ding Y; Chen Y; Hou M; Sun L; Qian G; Qin L; Lv H
Eur J Pharmacol; 2021 May; 899():173985. PubMed ID: 33652059
[TBL] [Abstract][Full Text] [Related]
10. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
[TBL] [Abstract][Full Text] [Related]
11. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S; Kimura M; Ishikawa T; Ohzeki T
Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105
[TBL] [Abstract][Full Text] [Related]
12. Assessment of risk factors for Korean children with Kawasaki disease.
Kim JJ; Hong YM; Yun SW; Han MK; Lee KY; Song MS; Lee HD; Kim DS; Sohn S; Ha KS; Hong SJ; Kim KJ; Park IS; Jang GY; Lee JK;
Pediatr Cardiol; 2012 Apr; 33(4):513-20. PubMed ID: 22105492
[TBL] [Abstract][Full Text] [Related]
13. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
Amano Y; Akazawa Y; Yasuda J; Yoshino K; Kojima K; Kobayashi N; Matsuzaki S; Nagasaki M; Kawai Y; Minegishi N; Ishida N; Motoki N; Hachiya A; Nakazawa Y; Yamamoto M; Koike K; Takeshita T
Pediatr Rheumatol Online J; 2019 Jul; 17(1):34. PubMed ID: 31269967
[TBL] [Abstract][Full Text] [Related]
14. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S; Kawashima H; Kashiwagi Y; Hoshika A
Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
[TBL] [Abstract][Full Text] [Related]
16. Association between maternal age and outcomes in Kawasaki disease patients.
Huang WD; Lin YT; Tsai ZY; Chang LS; Liu SF; Lin YJ; Kuo HC
Pediatr Rheumatol Online J; 2019 Jul; 17(1):46. PubMed ID: 31324255
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase genetic polymorphisms and susceptibility to Kawasaki disease in Taiwanese children.
Weng KP; Hsieh KS; Huang SH; Wu HW; Chien JH; Lin CC; Tang CW; Ou SF; Huang SJ; Ger LP
J Microbiol Immunol Infect; 2016 Oct; 49(5):788-796. PubMed ID: 26066543
[TBL] [Abstract][Full Text] [Related]
18. High neutrophil : lymphocyte ratio is associated with refractory Kawasaki disease.
Cho HJ; Bak SY; Kim SY; Yoo R; Baek HS; Yang S; Hwang IT; Ban JE
Pediatr Int; 2017 Jun; 59(6):669-674. PubMed ID: 28097746
[TBL] [Abstract][Full Text] [Related]
19. Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
Armaroli G; Verweyen E; Pretzer C; Kessel K; Hirono K; Ichida F; Okabe M; Cabral DA; Foell D; Brown KL; Kessel C
Arthritis Rheumatol; 2019 May; 71(5):792-804. PubMed ID: 30447136
[TBL] [Abstract][Full Text] [Related]
20. Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease.
Kobayashi T; Inoue Y; Otani T; Morikawa A; Kobayashi T; Takeuchi K; Saji T; Sonobe T; Ogawa S; Miura M; Arakawa H
Pediatr Infect Dis J; 2009 Jun; 28(6):498-502. PubMed ID: 19504733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
